Font Size: a A A
Keyword [MEK inhibitor]
Result: 1 - 20 | Page: 1 of 1
1. PD98059, A Selective Mek Inhibitor, Effect On The Proliferation And Apoptosis Of HepG2 Cell
2. The Effects Of MEK Inhibitor PD98059,Astragalus Membranaceus Extraction On Nonalcoholic Fatty Liver Disease In Rats
3. The Effects Of MEK Inhibitor PD98059 And Astragalus Membranaceus Extraction On Expression Of Sterol Regulatory Element Binding Protein-1,suppressor Of Cytokine Signaling-3 In Rats With Nonalcoholic Fatty Liver Disease
4. The Influence Of Danshen Root On Microglia Activation After Spinal Cord Injury And Preliminary Clinical Application
5. The Antitumor Effect And Mechanism Of CK2Inhibitor CX-4945Alone And Combination With MEK Inhibitor PD-325901in Head And Neck Squamous Carcinoma Cells
6. MEK Inhibitor Enhances Sensitivity To Chemotherapeutic Drugs In Multidrug Resistant Hepatocellular Carcinoma Cells
7. Inhibitory Effect Of Combined With PI3K Inhibitor And MEK Inhibitor On The Proliferation Of Cisplatin-resistance Ovarian Cancer Cell Line
8. Study On MEK Inhibitors Of Series Compounds For Anti-Tumor Effect On A549 Cells In Vitro
9. The Mechanism Research Of MEK Inhibitor And ANTI-TIM3 On The Inhibition Of Melanoma Growth And Metastatization
10. Study Of Synergistic Effect And Mechanism Of MTOR Inhibitor Rapamycin Combined With MEK Inhibitor PD98059 On Gastric Cancer Cell
11. Design,Synthesis And Biological Evaluation Of The Novel MEK Inhibitor KZ-001 And Radioprotector XH-105
12. Design And Synthesis Of Amido Derivatives Derived From C-3 Position Of Oleanolic Acid
13. Combination Treatment Of Breast Cancer Cells With Sulindac Derivative K-80003 And MEK Inhibitor GDC-0973
14. Afatinib Incombination With MEK Inhibitor On NCI-H522,A549,UM-SCC-74B And JHU-O28 Cell Lines
15. KRAS Mutation And Protein Levels In-gastric Signet Ringcell Carcinoma Cancer Patients And Response To MEK Inhibitor
16. A Combinatorial Strategy For Targeting Papillary Thyroid Carcinoma With SHP099 And Selumetinib
17. Combination Therapy With KRAS-MEK Inhibitors And Radiation Enhances Anticancer Immunity In KRAS Mutated Tumor Models
18. Experimental Study Of MEK Inhibitor Combined With Oxaliplatin In Inhibiting Cervical Cancer Based On Immunoregulatory Pathway
19. The Treatment Of KRAS Mutant Gastric Cancer And Its Mechanism By Dual-target Combination Therapy
20. Safety And Tolerability Of Combined BRAF And MEK Inhibition Versus BRAF Inhibition Alone In Patients With Advanced Melanoma
  <<First  <Prev  Next>  Last>>  Jump to